Advanced glycation end product in diabetic rat skeletal muscle in vivo

Pathobiology

Volumn 73, Issue 5, 2007, Pages 244-251

  Snow, LeAnn M ^a   Lynner, Christa B ^a   Nielsen, Erin M ^a   Neu, Hillari S ^a   Thompson, LaDora V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Advanced glycation end products; CML; Diabetes mellitus; Immunohistochemistry; N (carboxymethyl) lysine; Skeletal muscle

Indexed keywords

ADVANCED GLYCATION END PRODUCT; LYSINE DERIVATIVE; MYOSIN HEAVY CHAIN; N EPSILON (CARBOXYMETHYL)LYSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL SIZE; CELL TRANSFORMATION; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CELL; MUSCLE FUNCTION; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; RAT; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 33847364828     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098210     Document Type: Article

References (24)

1. Andersen H, Poulsen P, Mogensen C, Jakobsen J: Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes 1996;45:440-445.
2. Andersen H: Muscular endurance in long-term IDDM patients. Diabetes Care 1998;21:604-609.
3. Regensteiner J, Bauer T, Reusch J, Brandenburg S, Sippel J, Vogelsong A, Smith S, Wolfel E, Eckel R, Hiatt W: Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol 1998;85:310-317.
4. Stephenson GM, O'Callaghan AO, Stephenson DG: Single-fiber study of contractile and biochemical properties of skeletal muscles in stretpzotocin-induced diabetic rats. Diabetes 1994;43:622-628.
5. Sanchez OA, Snow LM, Lowe DL, Serfass RC, Thompson LV: Effects of endurance exercise-training on single fiber contractile properties of insulin-treated streptozotocin-induced diabetic rats. J Appl Physiol 2005;99:472-478.
6. Ahmed N: Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 2005;67:3-21.
7. Singh R, Barden A, Mori T, Beilin L: Advanced glycation end-products: a review. Diabetologia 2001;44:129-146.
8. Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper M: Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia 2001;44:108-114.
9. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, Bucala R: Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 1993;143:1649-1656.
10. Vlassara H, Palace M: Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med 2003;70:232-241.
11. Ramamurthy B, Höök P, Jones A, Larsson L: Changes in myosin structure and function in response to glycation. FASEB J 2001;15:2415-2422.
12. Alt N, Carson JA, Alderson NL, Wang Y, Nagai R, Henle T, Thorpe S, Baynes J: Chemical modification of muscle protein in diabetes. Arch Biochem Biophys 2004;425:200-206.
13. Armstrong R, Phelps R: Muscle fiber type composition of the rat hindlimb. Am J Anat 1984;171:259-272.
14. Basta G, Schmidt AM, DeCaterina R: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004;63:582-592.
15. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S: Nε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996;35:8075-8083.
16. Snow LM, McLoon L, Thompson LV: Adult and developmental myosin heavy chain isoforms in soleus muscle of aging Fischer Brown Norway rat. Anat Rec A Discov Mol Cell Evol Biol 2005;286:866-873.
17. Snow LM, Sanchez OA, McLoon L, Serfass RC, Thompson LV: Effect of endurance exercise on myosin heavy chain isoform expression in diabetic rats with peripheral neuropathy. Am J Phys Med Rehabil 2005:84:770-779.
18. Cotter M, Cameron N, Lean D, Robertson S: Effects of long-term streptozotocin diabetes on the contractile and histochemical properties of rat muscles. Quart J Exp Physiol 1989;74:65-74.
19. Medina-Sanchez M, Rodriguez-Sanchez C, Vega-Alvarez J, Menendez-Pelaez A, Perez-Casas A: Proximal skeletal muscle alterations in streptozotocin-diabetic rats: a histochemical and morphometric analysis. Am J Anat 1991;191:48-55.
20. Charlton M, Balagopal P, Nair K: Skeletal muscle myosin heavy chain synthesis in type 1 diabetes. Diabetes 1997;46:1336-1340.
21. Zhang X, Chinkes D, Wolf S, Wolfe R: Insulin but not growth hormone stimulates protein anabolism in skin wound and muscle. Am J Physiol 1999;276:E712-E720.
22. Snow L, Sanchez O, McLoon L, Serfass R, Thompson L: Myosin heavy chain isoform immunolabelling in diabetic rats with peripheral neuropathy. Acta Histochem 2005;107:221-229.
23. Rojas A, Morale M: Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci 2004;76:715-730.
24. Jakus V, Rietbrock N: Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 2004;53:131-142.